(+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man
- PMID: 3129007
- PMCID: PMC1386475
- DOI: 10.1111/j.1365-2125.1988.tb03292.x
(+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man
Abstract
1. gamma-L-glutamyl-L-dopa (gludopa) was given by intravenous infusion to six healthy salt-replete men on two occasions, with and without pretreatment with (+)-sulpiride. 2. Gludopa increased sodium excretion, glomerular filtration rate and effective renal plasma flow whilst decreasing plasma renin activity. 3. (+)-sulpiride had no significant effect on baseline natriuresis, renal haemodynamics or plasma renin activity, but significantly attenuated the rise in sodium excretion, glomerular filtration rate and effective renal plasma flow produced by gludopa. 4. (+)-sulpiride abolished the acute fall in plasma renin activity seen with gludopa. 5. (+)-sulpiride raised serum prolactin concentration but did not affect the ris in urine dopamine excretion rate caused by gludopa. 6. Gludopa exerts its renal effects by stimulating specific dopamine receptors which are principally of the DA1 subtype.
Similar articles
-
Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.Br J Clin Pharmacol. 1986 May;21(5):497-502. doi: 10.1111/j.1365-2125.1986.tb02831.x. Br J Clin Pharmacol. 1986. PMID: 3087398 Free PMC article.
-
The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man.Br J Clin Pharmacol. 1989 Jun;27(6):811-22. doi: 10.1111/j.1365-2125.1989.tb03444.x. Br J Clin Pharmacol. 1989. PMID: 2527048 Free PMC article. Clinical Trial.
-
The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.Br J Clin Pharmacol. 1988 Feb;25(2):195-201. doi: 10.1111/j.1365-2125.1988.tb03291.x. Br J Clin Pharmacol. 1988. PMID: 3129006 Free PMC article.
-
Five years' experience with gamma-L-glutamyl-L-dopa: a relatively renally specific dopaminergic prodrug in man.J Auton Pharmacol. 1990;10 Suppl 1:s103-8. doi: 10.1111/j.1474-8673.1990.tb00235.x. J Auton Pharmacol. 1990. PMID: 2129121 Review.
-
Dopamine, the kidney and essential hypertension studies with gludopa.Clin Exp Hypertens A. 1987;9(5-6):977-86. doi: 10.3109/10641968709161460. Clin Exp Hypertens A. 1987. PMID: 3113781 Review.
Cited by
-
The renal effects of atrial natriuretic peptide in man are not attenuated by (+)-sulpiride.Br J Clin Pharmacol. 1989 Jan;27(1):13-8. doi: 10.1111/j.1365-2125.1989.tb05329.x. Br J Clin Pharmacol. 1989. PMID: 2523227 Free PMC article.
-
Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.Br J Clin Pharmacol. 1989 Dec;28(6):683-94. doi: 10.1111/j.1365-2125.1989.tb03561.x. Br J Clin Pharmacol. 1989. PMID: 2532921 Free PMC article. Clinical Trial.
-
The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man.Eur J Clin Pharmacol. 1988;35(2):137-41. doi: 10.1007/BF00609242. Eur J Clin Pharmacol. 1988. PMID: 3056728
-
The pharmacokinetics of gamma-glutamyl-L-dopa in normal and anephric rats and rats with glycerol-induced acute renal failure.Br J Pharmacol. 1990 Oct;101(2):301-6. doi: 10.1111/j.1476-5381.1990.tb12705.x. Br J Pharmacol. 1990. PMID: 2124159 Free PMC article.
-
Disposition of gamma-glutamyl levodopa (gludopa) after intravenous bolus injection in healthy volunteers.Br J Clin Pharmacol. 1991 Apr;31(4):419-22. doi: 10.1111/j.1365-2125.1991.tb05556.x. Br J Clin Pharmacol. 1991. PMID: 1904753 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources